Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

NCT05698979 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT05698979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05698979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
February 29, 2028
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

buerger disease, raynaud syndrome